Drug intelligence / Profile preview

Sputnik M

Development stage
Phase 3
Lead developer
Gamaleya Center
Modality
Viral Vector Vaccines → Recombinant Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
Administration
Intramuscular
01

Overview

Sputnik M (Gam-COVID-vac M) is a recombinant adenovirus-based vaccine designed specifically for children and adolescents to build immunity against SARS-CoV-2, the virus that causes COVID-19[9]. Like its parent vaccine Sputnik V, it consists of two components: 1. Component I: A recombinant adenoviral vector based on human adenovirus serotype 26 (rAd26) carrying the gene for the S-protein of the SARS-CoV-2 virus 2. Component II: A vector based on human adenovirus serotype 5 (rAd5) carrying the gene for the S-protein of the SARS-CoV-2 virus The vaccine is produced with the HEK293 cell line and is formulated as a liquid containing 10¹¹ viral particles per 0.5 mL dose[9]. The technological platform of adenovirus-based vectors allows for relatively quick development of new vaccines by modifying the initial carrier vector with genetic material from emerging viruses. This approach is designed to provoke a strong response from the human immune system.

Brand names
Sputnik M
02

Targets

SARS-CoV-2 spike

Beyond the preview

Go deeper on Sputnik M.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sputnik M.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call